Emerald Health Announces Exit From Cannabis Industry

And another one bites the dust. Emerald Health Therapeutics (CSE: EMH), one of the first players to enter the Canadian cannabis sector, this morning announced that it is getting out of both recreational and medical cannabis in Canada entirely.

The announcement comes just weeks after the firm revealed it has partnered with HYTN Cannabis to launch cannabis beverages in the country. Instead, the company has begun the process of soliciting purchasers for its Canadian cannabis assets, the proceeds of which will be used to strengthen the firms capital position.

The move is being made as the firm looks to cut back its monthly net cash burn. Instead, the firm will be pivoting to pharmaceutical development due to the expertise and experience in the field among its board members.

In making the announcement, Chairman Jim Heppell commented, “in a market with a very large number of cannabis operating licenses, increasing competition and declining retail prices, the path to achieving profitability and increasing shareholder value has been very challenging.”

The firms CEO, Riaz Bandali, will also be stepping down from his role with the company effective December 31.

Emerald Health last traded at $0.08 on the CSE.


Information for this briefing was found via Sedar and Emerald Health Therapeutics. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

One Response

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

Giant Mining Encounters Native Copper As Hole MHB-34 Hits 563 Metres Depth

Verses Hits Commercialization Stage With Genius AI Platform

Related News

Village Farms Requests $5.94 Million Refund From Pure Sunfarms

It appears that Village Farms (TSX: VFF) (NASDAQ: VFF) is taking a step back from...

Thursday, January 16, 2020, 05:35:29 PM

Emerald Health Sees Revenues Decline 32% To $2.9 Million In First Quarter 2020

Revenues continue to decline for Emerald Health Therapeutics (TSXV: EMH), with the firm posting first...

Friday, June 19, 2020, 08:00:00 AM

Emerald Health Signs Supply Agreement with Stenocare

Emerald Health Therapeutics (TSXV: EMH) is Stenocare’s new supplier of choice following the fallout earlier...

Thursday, November 7, 2019, 09:34:55 AM

Emerald Health Therapeutics To Begin Trading On CSE April 27

Emerald Health Therapeutics (TSXV: EMH) has finalized the date on which it is to delist...

Friday, April 23, 2021, 08:55:51 AM

Village Farms Acquires Remainder Of Pure Sunfarms For C$79.9 Million

Well, it looks like Raymond James was on to something. This afternoon, it was announced...

Tuesday, September 8, 2020, 03:42:23 PM